Pharma Journalist -

Rigel Pharmaceuticals, Inc. and Forma Therapeutics, Inc. announced that they have entered into an exclusive, worldwide license agreement to develop, manufacture and commercialize…
Read More...

SAE Media Group reports: Newly released brochure and new sponsors announced for the Pre-filled Syringes San Francisco, this September 19 - 20, 2022. SAE Media Group is proud to host…
Read More...

Synthego announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that…
Read More...

TransCode Therapeutics, Inc. the RNA oncology company, and The University of Texas MD Anderson Cancer Center (“MD Anderson”), announced a strategic alliance to advance TransCode’s…
Read More...

Gamida Cell Ltd.  announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment…
Read More...

Xeris Biopharma Holdings, Inc. announced that Tetris Pharma—its commercialization partner for Ogluo in the UK, EEA, and Switzerland—will be acquired by Arecor Therapeutics (AIM: AREC),…
Read More...

Krystal Biotech, Inc. announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate KB407 in a clinical…
Read More...

GreenLight Biosciences and Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved STELARA (ustekinumab) for the treatment of…
Read More...